Author: Navneet S

Neuralink, the brain-machine interface company founded by Elon Musk, recently revealed that they have encountered a setback in its first human trial. Reports indicate that tiny wires implanted in the brain of its inaugural patient have retracted from their intended position, raising concerns about the efficacy and safety of the innovative technology. According to sources familiar with the matter, Neuralink was aware of the potential for wire retraction based on animal testing conducted prior to receiving U.S. approval for human trials last year. Despite this foreknowledge, the company deemed the risk low enough to proceed without implementing a redesign of…

Read More

With more and more medical professionals coming to the forefront of a holistic care system, it’s difficult to locate the right administrative and management software that uplifts the diverse needs of your clinic. Clinic management software is expected to be simple, highly customizable, and lightweight. They are such that multiple employees can access and modify professional schedules on the app so that the clinic runs in sync. Power Diary is one such innovative medical management application that has caused quite a stir in the industry. Its unique set of features and subscription plans have made it quite a complicated choice!…

Read More

Successful practice management is integral to retaining medical clients – and these days, the most helpful tool to do that is clinic management software. However, with the availability of many clinic practice management software, it can be a tough job to choose the one that best suits your needs. From the analysis and security of patient data to the smooth generation of invoices, there is a lot that medical software must handle. If you are looking for a good management software, then Jane is the one you should try. With all the features it offers, it’s probably one of the…

Read More

Everything is being done on the internet these days! Then why not use this resource to transform our careers as healthcare providers? With the same goal in mind, more and more doctors, nurses, pharmacists, radiologists, etc are moving towards the use of telemedicine platforms. These platforms simplify complex disorders, provide accurate and latest information on important areas of research, and allow professionals to network with one another freely. How Do We Define Telemedicine in 2024? In 2024, telemedicine to every one of the versatile services available for patients and care providers in the virtual world – consultations, remote monitoring devices,…

Read More

Contraline, led by founder Kevin Eisenfrats, has emerged as a frontrunner in this field with its innovative non-hormonal male contraceptive, offering a promising solution to the ongoing discourse surrounding family planning. Eisenfrats, inspired by societal shifts and the impact of media, founded Contraline after witnessing the realities portrayed in MTV’s “16 and Pregnant.” Despite decades of research, male contraception remained elusive until Contraline’s breakthrough. Their latest product, ADAM, a sperm-blocking gel injected into the scrotum, is now undergoing clinical trials in Australia. “Believe it or not, people have actually been working on male contraceptives since the female contraceptive pill came…

Read More

Samsung Medison, the medical device unit of Samsung Electronics specializing in diagnostic imaging devices, has announced plans to acquire Sonio, a Paris-based startup renowned for its AI-powered software designed for ultrasound workflows. The acquisition, valued at approximately $92.7 million (KRW 126 billion), signifies Samsung Medison’s commitment to advancing AI-driven imaging solutions in the healthcare sector. Sonio’s AI assistant targets obstetricians and gynecologists, offering assistance in the evaluation and documentation of ultrasound exams. One of its flagship products, Sonio Detect, has received regulatory clearance in the United States from the FDA (Food and Drug Administration) for its innovative use of deep…

Read More

Artificial Intelligence is the future of all technological progress, including the growth of the medical sector. It can already be seen that AI healthcare companies are developing complex artificial thought concepts that can learn from every experience and expand their learning base constantly. Technology has made it possible for AI to become cheap and accessible for all, creating a new market for digital diagnosis, caregiving, and even therapy that is not only beneficial for these companies but even more so for the patients who are availing these services. Today, we are discovering the top medical AI companies that are paving…

Read More

The biggest revolution of the 21st century is digitalization, so all services, including healthcare, have now become more and more dependent on smart technology for appointments, diagnosis, treatment, prescription, medicine management, and day-to-day caregiving. Most doctors and mental health professionals have even started providing consultations and therapy over the internet! Thankfully, this confusing hybrid of the real and virtual world can be comprehended, recorded, and managed in a single place with the help of modern healthcare software solutions. Here is an introduction to the world of medical management software and a list of the best options available in the market…

Read More

The med tech startup neuroClues, based in France and Belgium, is using innovative eye-tracking technology to revolutionize the diagnosis of neurodegenerative conditions. Their aim is to make healthcare solutions more accessible and efficient. Founded by neuroscience researchers, the company’s innovative approach incorporates AI-driven analysis to enhance the accuracy of diagnoses. Starting with a focus on Parkinson’s disease, neuroClues aims to streamline the diagnostic process by replacing traditional methods with its proprietary portable headsets capable of capturing eye movements at a remarkable 800 frames per second. This high-speed data capture enables clinicians to conduct rapid analysis, providing valuable insights into neurological…

Read More

Innovaccer, the innovative health tech startup renowned for its prowess in aggregating patient data across diverse systems and care settings, is reported to be in the final stages of negotiations with investors to secure a substantial sum of $250 million in a fresh financing round. Multiple sources familiar with the matter disclosed this information to TechCrunch on the condition of anonymity due to the confidentiality of the details. The ongoing talks surrounding the new funding round suggest a valuation range of $2.5 billion to $3 billion for the nine-year-old company, showcasing its robust growth trajectory and market significance. Innovaccer’s pioneering…

Read More

Walmart announced on Tuesday its decision to close numerous health centers and discontinue its telehealth business because of significant operating and reimbursement costs. The closure affects 51 one-stop health centers that were opened since 2019 across five states. Initially, Walmart had ambitious plans to establish over 75 clinics offering a range of services, including dental, medical, and behavioral health. These clinics, conveniently located adjacent to Walmart Supercenter locations, aimed to provide comprehensive care to patients, including X-rays and deep teeth cleanings. In a blog post, Walmart cited the challenging reimbursement environment and rising operating costs as primary factors contributing to…

Read More

Labcorp, a leading laboratory service provider, has made a significant move in the healthcare industry by announcing its acquisition of assets from Invitae Corp, a genetic test maker that filed for bankruptcy earlier this year. The acquisition comes after Invitae sought voluntary Chapter 11 protection in February, signaling its intent to undergo a sale process. According to statements released by both companies, Labcorp will acquire all of Invitae’s assets as part of the bankruptcy proceedings. The acquisition, valued at $239 million in cash consideration along with other non-cash considerations, underscores Labcorp’s strategic vision to expand its capabilities and offerings in…

Read More

The Federal Trade Commission (FTC) has taken a significant stride in bolstering consumer protection in the digital health realm with its recent overhaul of the Health Breach Notification Rule (HBNR). Now, health apps and analogous technologies are brought under stringent scrutiny, filling a regulatory void that previously left them outside the scope of existing legislation like HIPAA. Under the revamped regulations, entities not covered by HIPAA, such as vendors of personal health records (PHR) and related entities, are mandated to promptly notify individuals, the FTC, and potentially the media in the event of a breach of unsecured personally identifiable health…

Read More

UnitedHealth Group has just announced the closure of its Optum Virtual Care telehealth business, signaling a shift within the company’s healthcare delivery model. Employees were informed of this decision last Thursday (April 18), with some being notified that their last day with the company would be in July, as reported by Seeking Alpha referencing Endpoints News. Upon reaching out for clarification, a spokesperson for UnitedHealth Group responded by highlighting the organization’s commitment to supporting affected team members during this transition. The company aims to provide job placement resources and is exploring opportunities to deploy individuals into available roles within the…

Read More

Food and Drug Administration (FDA) has approved the first-ever “prescription digital therapeutic” smartphone app, Rejoyn, designed to aid in the treatment of major depressive disorder (MDD). Developed by Otsuka America Pharmaceutical, Rejoyn is intended to be used alongside traditional antidepressant medication and talk therapy, serving as an innovative adjunctive treatment for individuals struggling with MDD symptoms. Dr. John Kraus, Executive Vice President and Chief Medical Officer at Otsuka, expressed enthusiasm about this milestone in mental health care. He emphasized that Rejoyn represents a promising additional treatment option that complements the current standard of care for MDD, highlighting its potential impact…

Read More

In a strategic move aimed at accelerating its path to profitability, Hinge Health, a leader in digital musculoskeletal care solutions, has confirmed a significant workforce reduction. The company, which is gearing up for a potential IPO, decided to cut approximately 10% of its workforce, affecting employees across various functions including engineering. According to exclusive insights obtained by TechCrunch, Hinge Health’s recent workforce adjustments are part of a broader initiative to enhance operational efficiency and refocus investment strategies. Prior to this reduction, Hinge Health boasted a workforce of more than 1,700 employees, marking this move as a substantial adjustment within the…

Read More

In a groundbreaking development, researchers at the U.S. National Institutes of Health (NIH) have leveraged artificial intelligence (AI) to revolutionize the imaging of cells within the eye. This pioneering work promises to significantly enhance our ability to diagnose and understand retinal diseases such as age-related macular degeneration. According to NIH, the application of AI has yielded remarkable improvements in imaging efficiency and clarity. The research team reported that with AI integration, imaging has accelerated by a remarkable factor of 100, while image contrast has been enhanced by 3.5-fold. These advancements represent a critical leap forward in the field of ophthalmic…

Read More

Neurovalens, a pioneering neurotechnology startup based in Belfast, has achieved a significant milestone with the recent clearance of its second head-mounted medical device by the U.S. Food and Drug Administration (FDA). This clearance marks a key advancement in the company’s mission to provide innovative noninvasive treatments for various neurological and metabolic conditions. The FDA’s approval allows Neurovalens to offer two prescription-based devices for specific medical conditions in the United States: one targeting generalized anxiety disorder (GAD) and the other addressing insomnia. These devices utilize noninvasive electrical stimulation of the brain and nervous system to deliver therapeutic effects. The GAD device…

Read More